Dimensional Fund Advisors LP Grows Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Dimensional Fund Advisors LP boosted its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 7.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,725,337 shares of the real estate investment trust’s stock after buying an additional 269,793 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Sabra Healthcare REIT were worth $71,640,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in SBRA. Rothschild Investment LLC lifted its position in shares of Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 889 shares during the period. Smartleaf Asset Management LLC grew its holdings in shares of Sabra Healthcare REIT by 97.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares during the period. Strengthening Families & Communities LLC acquired a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth approximately $29,000. Danske Bank A S purchased a new position in Sabra Healthcare REIT in the 3rd quarter valued at approximately $30,000. Finally, Larson Financial Group LLC increased its stake in Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 553 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently issued reports on SBRA. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Wells Fargo & Company raised their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Raymond James Financial started coverage on Sabra Healthcare REIT in a research note on Wednesday, June 17th. They set an “underperform” rating for the company. Citizens Jmp boosted their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a research report on Wednesday, July 22nd. Finally, Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and an average price target of $22.25.

Sabra Healthcare REIT Trading Down 0.7%

Shares of Sabra Healthcare REIT stock opened at $21.17 on Friday. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $22.77. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. The business has a 50 day moving average price of $19.77 and a 200 day moving average price of $19.92. The company has a market capitalization of $5.34 billion, a P/E ratio of 33.60, a P/E/G ratio of 1.65 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. The firm had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.Sabra Healthcare REIT’s quarterly revenue was up 20.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.37 EPS. Sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current fiscal year.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.